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DNA methylation is a biochemical process where a DNA base, usually cytosine, is enzy-
matically methylated at the 5-carbon position. An epigenetic modiﬁcation associated with
gene regulation, DNA methylation is of paramount importance to biological health and
disease. Recently, the quest to unravel the Human Epigenome commenced, calling for a
modernization of previous DNA methylation proﬁling techniques. Here, we describe the
major developments in the methodologies used over the past three decades to exam-
ine the elusive epigenome (or methylome). The earliest techniques were based on the
separation of methylated and unmethylated cytosines via chromatography. The follow-
ing years would see molecular techniques being employed to indirectly examine DNA
methylation levels at both a genome-wide and locus-speciﬁc context, notably immuno-
precipitation via anti-5′methylcytosine and selective digestion with methylation-sensitive
restriction endonucleases.With the advent of sodium bisulﬁte treatment of DNA, a deam-
ination reaction that converts cytosine to uracil only when unmethylated, the epigenetic
modiﬁcation can now be identiﬁed in the same manner as a DNA base-pair change. More
recently, these three techniques have been applied to more technically advanced systems
such as DNA microarrays and next-generation sequencing platforms, bringing us closer to
unveiling a complete human epigenetic proﬁle.
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INTRODUCTION
When theHumanGenomeProjectwas completed in 2003,50 years
after the discovery of theDoubleHelix, it was clear that the full pic-
ture had yet to be elucidated (Claverie, 2001; Kruglyak and Nick-
erson, 2001; Lander et al., 2001). The sequence of bases that make
up the human genome alone was not enough to account for what
makes the human populace so diverse. Five years later, giant leaps
in technological advances paved the way for the announcement
of the 1000 Genomes Project, aiming to sequence the genomes of
1000 anonymous individuals to visualize the genomic differences
that make each person unique (Kaiser, 2008; Durbin et al., 2010).
However,mounting evidence from the past fewdecades is pointing
to a new set of variables that contribute to our individuality. The
HumanGenomeProject has already unveiled the genetic hardware
needed to create a person, but the search for the biochemical soft-
ware is still underway. The next major milestone in deﬁning life is
The Epigenome: the sum of heritable chemical and chromosomal
modiﬁcations to genetic material that inﬂuences the development
of complex organisms. We focus on DNA methylation, the incor-
poration of a methyl group in mostly a CpG motif, which was ﬁrst
found to inﬂuence gene expression in 1975 (Holliday and Pugh,
1975; Riggs, 1975).
At the time, it had been accepted that bacteria were capable
of methylating both adenine and cytosine residues while higher
organisms possessed mainly methylated cytosines (Wyatt, 1950;
Doskocil and Sorm, 1962;Meselson et al., 1972; Smith et al., 1973).
The enzyme DNA adenine methylase (Dam) in E. coli speciﬁ-
cally methylates GATC sequences, and DNA cytosine methylase
(Dcm) methylates the duplex sequence CCWGG (W denotes A
or T; Casadesús and Low, 2006). As a defence mechanism, bac-
teria use a plethora of very speciﬁc DNA digesting enzymes to
ward off invading phages. These enzymes cleave DNA based on
a target nucleotide sequence, usually a palindrome motif of sev-
eral bases, so the enzymes have no way of differentiating between
viral and bacterial DNA. A restriction/modiﬁcation mechanism
allows bacterial cells to protect their own DNA from restriction
enzymes by introducing a DNA methylation signature into newly
synthesized strands (reviewed in Bickle and Krüger, 1993). It was
understood that these bacteria carried out methylation in a highly
speciﬁc manner, but the signiﬁcance of cytosine methylation in
eukaryotes was not fully realized until later. Even though there
was no direct evidence of a speciﬁc methylating enzyme, Holli-
day and Pugh (1975) based their early DNA methylation model in
eukaryotes on the mechanisms of bacterial methylating enzymes,
and the fact that methyl groups are distributed about the genome
in a non-random manner. Amongst their concluding remarks,
they suggest “it may be signiﬁcant that the doublet CpG is the
most highly methylated,” oblivious to how important this state-
ment would be in context of the huge strides in the ﬁeld to come
in the following decades. Independently, a similar paper by Arthur
Riggs presented the same hypothesis, this time focusing on the
role of DNA methylation in X-inactivation and in mediating DNA
binding proteins (Riggs, 1975). Both papers brought considerable
attention to the phenomena of DNA methylation, whilst alluding
to a new somatically heritable information system that lay within
the genetic code.
DNA methylation is now considered to be an important mol-
ecular mechanism in a number of biological processes including
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genomic imprinting, X-inactivation, tissue speciﬁc gene expres-
sion, and possibly trans-generational effects (Riggs, 1975; Razin
and Ceder, 1991; Li et al., 1993). However, the methods to ana-
lyze genome-wide DNA methylation patterns is still evolving. We
review the development of DNA methylation methodologies from
the late 1970s to the present day (Figure 1).
EARLY NON-SPECIFIC METHODS
Early non-speciﬁc methods are summarized in Table 1 and
described in more detail below.
HPLC AND TLC METHODS
Ambitious attempts to map the Epigenome started long before the
era of theHumanGenome. In the fallout of theHolliday andRiggs
papers (Holliday and Pugh, 1975; Riggs, 1975), methods for mea-
suring and proﬁling these epigenetic variations were put forward.
The earliest breaches into the epigenetic landscape were based on
the separation of methylated and unmethylated deoxynucleosides.
The most signiﬁcant technique at the time was the separation of
purines and pyrimidines by Vischer and Chargaff (1948) through
paper chromatography. In the context of DNA methylation, Kuo
et al. (1980) established an analytical technique to measure 5-
methylcytosine (5mC) quantitatively using reversed-phase high
performance liquid chromatography (RP-HPLC). This method
is based on the quantitative hydrolysis of DNA using DNase I
and nuclease P1, followed by treatment with alkaline phosphatase.
The individual bases can then be monitored based on their UV
absorbances at 254 and280 nm.TheRP-HPLCmethodwas further
improved throughout the 1980s (Gomes and Chang, 1983; Patel
and Gopinathan, 1987) with incorporation of mass spectrometry
with standard HPLC by Annan et al. (1989). Of course, HPLC
based methods require specialized machinery, so naturally, alter-
native separation techniques came into use. Bestor et al. (1984)
used two restriction endonucleases, Msp1 and Taq1 to discrimi-
nate between methylated and unmethylated-CpG residues in their
restriction sites,CCGG andTCGA respectively. DigestedDNAwas
5′ end-labeled with a 32P isotope and subsequently hydrolyzed to
deoxyribonucleotide monophosphate followed by separation in
two dimensions via thin-layer chromatography (TLC). Quanti-
tative measurement of DNA methylation is based on the relative
intensity between C and 5mC fractions after separation.
The RP-HPLC and TLC methods described above were only
capable of measuring the relative ratio of methylated cytosine
residues against unmethylated cytosines. Although this has been
useful formany applications, such as comparing theDNAmethyla-
tion amongst different animal or plant species (Wagner and Cape-
sius, 1981; Gama-Sosa et al., 1983), fully charting the epigenome
was far out of reach using these methods. More speciﬁc and infor-
mative methods are now in practice to detect 5-methylcytosine,
but today, HPLC and TLC based methods are now best suited
to detecting hydroxymethylcytosine, an epigenetic modiﬁcation
once believed to be only found in bacteriophages, but recently dis-
covered to be abundant in humans and animals (Kriaucionis and
Heintz, 2009; Tahiliani et al., 2009).
RADIOLABELING
Instead of trying to separate and observe individually methy-
lated bases at a high resolution, more indirect approaches have
been devised. It is possible to enzymatically incorporate tritium
labeled methyl groups from S-adenosylmethionine to unmethy-
lated cytosines. Assays have been developed using bacterial SssI
methyltransferase to incorporate radiolabeled methyl groups into
CpG sites. The level of radioactivity measured is inversely propor-
tional to the level of DNA methylation of a sample (Wu et al., 1993;
Duthie et al., 2000).
ANTI-METHYLCYTOSINE
Other alternative methods include the wide range of immunolog-
ical DNA methylation assays that suddenly appeared after it was
FIGURE 1 |Timeline of DNA methylation analysis.The techniques for DNA
methylation analysis have developed from the ability to simply measure the
amount of 5-methylcytosine within a particular genome in the early 1980s to a
variety of basic comparative methods involving methylation-sensitive
restriction enzymes, immunoprecipitation or bisulﬁte sequencing usually in
combination with PCR up to the late 1990s. The introduction of microarray
technology and next-generation sequencing saw the adaption of these earlier
methods to these newer platforms during the 2000s. More details on
microarray/beadchip technologies and next-generation sequencing are
described inTables 1 and 2. RP-HPLC, reversed-phase high performance liquid
chromatography; 5mC, 5-methylcytosine; MS-SnuPe, methylation-sensitive
single nucleotide primer extension; COBRA, combined bisulﬁte restriction
analysis; AP-PCR, arbitrarily primed PCR; AIMS, ampliﬁcation of
inter-methylated sites; RRBS, reduced representation bisulﬁte sequencing.
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Table 1 | Summary of early non-specific methods.
Method Author
Restriction endonuclease digestion, isotope
incorporation, andTLC
Bestor et al. (1984)
Polyclonal leporine antibody, radiolabeled DNA Adouard et al. (1985)
RP-HPLC Kuo et al. (1980)
HPLC, mass spectrometry Annan et al. (1989)
SssI methyltransferase tritium labeling Wu et al. (1993)
Monoclonal, isothiocyanate labeled ﬂuorescent
anti-5mC
Oakeley et al. (1997)
TLC, thin-layer chromatography; RP-HPLC, reverse phase high performance liquid
chromatography; Anti-5mC, anti-5-methylcytosine.
ﬁrst found that methylcytosine was accessible to speciﬁc antibod-
ies in 1985 (Adouard et al., 1985). This vital development paved the
way for the possibility to chart the DNA methylation landscape on
a cell to cell basis. TheAdouardpaper introduces the quantiﬁcation
of radiolabeled DNA retained by leporine polyclonal antibodies,
visualized under electron microscopy. Later, confocal ﬂuorescence
microscopy was used to detect global changes in methylation
patterns. Using anti-5mC monoclonal antibodies and secondary
antibodies labeled with ﬂuorescent isothiocyanate, Oakeley et al.
(1997) devised an efﬁcient method to study global changes in
DNA methylation during tobacco pollen maturation. The use of
anti-5mC has been widely applied since its introduction but most
notably in the investigation of DNA methylation changes during
embryonic development. The mammalian genome undergoes a
mass loss of DNA methylation, followed by remethylation during
early embryonic development.Although this was established using
methylation-sensitive restriction enzymes (Monk et al., 1987) a
more precise proﬁle was obtained with anti-5mC antibody in
conjunction with confocal imaging (Santos et al., 2002). They
found that the paternal genomeundergoes selective demethylation
immediately after spermdecondensation,and is complete after 90–
120min. The de novo methylases DNMT3a and DNMT3b restore
DNA methylation later in development, which is maintained by
DNMT1 throughout life (Bestor, 2000).
Out of the methods discussed so far, the immunological
approach has seen the most signiﬁcant improvements and novel
applications over the past decade alone, due to advances in
microarray technology. Thesewill be discussed inmore detail later.
EARLY DIFFERENTIAL GENE METHYLATION ANALYSIS
Early differential gene methylation methods are summarized in
Table 2 and described in more detail below.
METHYLATION-SENSITIVE RESTRICTION ENZYMES
Restriction enzymes cleave DNA through recognition of speciﬁc
nucleotidemotifs.Amongst the variety of different types of restric-
tion enzymes that exist, only some are sensitive to DNA methyla-
tion. Given the considerable amount of redundancy amongst the
many different palindromemotifs targeted by restriction enzymes,
many pairs of restriction enzymes exist that both cut at the same
nucleotide sequence but with differing sensitivity to DNA methy-
lation signatures. Isoschizomer pairs like this can be used to
Table 2 | Summary of early differential gene methylation analysis.
Method Author
Isoschizomer digestion
and isotope incorporation
Cedar et al. (1979)
HpaII PCR Singer-Sam et al. (1990)
Methylation-speciﬁc RLGS Kawai et al. (1993), Hayashizaki et al. (1993)
AP-PCR Liang et al. (2002)
AIMS Frigola et al. (2002)
RLGS, restriction landmark genome scanning; AP-PCR, arbitrarily primed poly-
merase chain reaction; AIMS, ampliﬁcation of inter-methylated sites.
discriminate between methylated and unmethylated regions of the
genome in a laboratory setting (Bird and Southern, 1978) and ini-
tially exempliﬁed in 1979withHpaII andMspI (Cedar et al., 1979).
Both recognize and cut at the same sequence, CCGG, but methy-
lation of the second C in this motif prevents digestion by HpaII.
Detectionof digestedDNA fragmentswas initially by radiolabeling
and two dimensional TLC. Later Southern blotting was employed
(Southern, 1975) for visualization followed by the introduction of
methylation-sensitive PCR-based methods in 1990 (Singer-Sam
et al., 1990). However, efﬁciency of the restriction enzymes was a
likely issue for these techniques.
DIFFERENTIAL GENOME-WIDE SCANNING
Restriction landmark genomic scanning (RLGS) is a genomic
scanning method that takes advantage of the speciﬁcity of restric-
tion endonucleases and allows a low resolution comparison of
genome-wide differences between individuals (Hatada et al.,
1991). Radiolabeled DNA is digested with two restriction enzymes
and separated in two dimensions. This produces an autoradi-
ograph proﬁle of thousands of spots spread through the gel, each
spot representing a restriction site. This method was adapted for
DNA methylation analysis (RLGS-M) by employing methylation-
sensitive restriction enzymes (Hayashizaki et al., 1993; Kawai et al.,
1993) to differentiatemethylation differences between individuals.
Later, simpler and less expensive genome-wide screening strate-
gies came into use. Using a single primer and two low-stringency
annealing steps, Liang et al. (2002) found that methylation pro-
ﬁles couldbeobtainedbydigestingDNAwithmethylation-speciﬁc
endonucleases followed by a PCR reaction with random primers.
This process is known as arbitrarily primed PCR (AP-PCR), and
is based on a method developed by Welsh and McClelland (1990)
initially used to identify bacterial species. AP-PCR was adapted
in order to scour tumor genomes for new differential methyla-
tion sites (Gonzalgo et al., 1997; Liang et al., 2002). Ampliﬁcation
of inter-methylated sites (AIMS) is a similar but more effec-
tive PCR-based approach.Methylation-sensitive isoschizomers are
employed that cleave DNA leaving a blunt end or an overhang.
These properties are exploited by the addition of linkers that only
ligate to the methylated sites with subsequent PCR ampliﬁcation.
Fingerprints composed of multiple anonymous bands represent
methylated regions of the genome are generated and can be excised
out and characterized individually (Frigola et al., 2002).
It should be noted that the methods discussed so far are lim-
ited in the context of other genetic techniques at the time. This is
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because in vitro ampliﬁcation of methylated DNA strands via PCR
causes the target strand to lose itsmethylation status. Themethods
so far have aimed to detect 5-methylcytosine as it manifests natu-
rally. On a genome-wide or gene-speciﬁc scale, these approaches
are limited. In order to advance to the stage of possibly sequencing
the epigenome, a new approach was needed.
THE SODIUM BISULFITE ERA
In 1970, a chemical interaction between sodium bisulﬁte and
pyrimidines was described that would have a colossal impact on
how DNA methylation is studied (Hayatsu et al., 1970). It was
found that uracil, thymidine, and deoxycytidine were subjected
to sulfonation at position six of their pyrimidine rings. Ten years
later, this model was extended to 5-methylcytosine although the
reaction takes place at a slower rate than cytosine (Wang et al.,
1980). Frommer et al. (1992) described in a classic paper that
the differing reaction rates of 5mC to C could be exploited to
analyze DNA methylation patterns in genomic DNA. Treating
DNA with sodium bisulﬁte, they proposed, will deaminate cyto-
sine residues into uracil at a much faster rate than 5mC. This
phenomenon made it possible to change a chemical modiﬁca-
tion of DNA to an easily detected genetic element. At the time,
Maxim and Gilbert sequencing was used to pinpoint the changes,
but the methods put forward by Frommer and colleagues would
be revised and reﬁned as technological advances in the subse-
quent years would pave the way for large scale, next-generation
sequencing.
The Frommer et al. (1992) paper marked somewhat of a rev-
olution in the ﬁeld. Now the elusive biochemical software could
be converted to more tangible genetic hardware. Although it was
initially described how bisulﬁte modiﬁcation could be used to
augment sequencing-based methods, the concept itself would be
used to formulate entirely new methods to probe the genome for
DNA methylation in the following years. These methods are based
on the treatment of DNA with bisulﬁte such that unmethylated
cytosines are converted to uracil and methylated cytosines remain
as cytosines. The approaches to detect these conversions are vari-
ous and are summarized in Table 3 and described in more detail
below.
Table 3 | Summary of methods using sodium bisulfite treatment.
Method Author
Ligation-mediated PCR Pfeifer et al. (1989)
Bisulﬁte sequencing Frommer et al. (1992)
MS-PCR Herman et al. (1996)
MS-SNuPE Gonzalgo and Jones (1997)
MS-SSCA Bianco et al. (1999)
MS-HRM Wojdacz and Dobrovic (2007)
Bisulﬁte treatment to create
new restriction sites
Sadri and Hornsby (1996)
MS-PCR, methylation-speciﬁc polymerase chain reaction; MS-SNuPE,
methylation-speciﬁc single nucleotide primer extension; MS-SSCA, methylation-
speciﬁc single-strand conformation analysis; MS-HRM, methylation-speciﬁc high
resolution melting.
GENE-SPECIFIC APPROACHES
Methylation-speciﬁc PCR (MS-PCR) was one of the ﬁrst innova-
tive methods to incorporate bisulﬁte conversion outside the con-
text of sequencing (Herman et al., 1996). Primers were designed
to discriminate between methylated and unmethylated regions of
DNA after bisulﬁte treatment, so primer sites that were origi-
nally methylated would undergo ampliﬁcation only. The nature
of this rapid assay eliminated the frequent false positives associ-
ated with previous PCR-based endonuclease methods; however
PCR bias was an issue. Technical advances in genomics and mole-
cular biology in more recent years have allowed MS-PCR take on a
new form.
Many of the new techniques introduced during the Sodium
Bisulﬁte Era followed a similar strategy; using well established
genetic techniques to detect DNA methylation since the elusive
epigenetic modiﬁcation could be converted into the more tangible
nucleotide variant. Methylation-sensitive single nucleotide primer
extension (MS-SNuPE) is based on a conventional genotyping
technique, single nucleotide primer extension (Kuppuswamy et al.,
1991). MS-SNuPE (Gonzalgo and Jones, 1997) uses a PCR step
after bisulﬁte conversion to amplify a desired fragment. Once the
product is isolated, primers speciﬁc for the ampliﬁed fragments
are used in another PCR stage, this time incorporating 32P dNTPs
which can be used to quantify the nucleotides that have been con-
verted during bisulﬁte treatment, therefore quantifying the level
of DNA methylation in the initial genomic DNA.
Basedonanotherwell-knownPCRmethod for resolving single-
base restriction fragment length polymorphisms (Poduslo et al.,
1991), methylation-sensitive single-strand conformation analysis
(MS-SSCA) is a method to screen and analyze DNA methylation
in a gene-speciﬁc manner (Bianco et al., 1999). Genomic DNA is
bisulﬁte treated and the gene of interest is ampliﬁed with PCR,
and then cut with frequently cutting restriction enzymes. The
digestion patterns of samples are compared to a methylation stan-
dard and variations in pattern imply changes in DNA methylation.
Methylationdifferences are characterizedusing a gel stabbing tech-
nique and sequencing (Wilton et al., 1997). This method has been
expanded by Suzuki et al. (2000) to include high performance
capillary electrophoresis (HPCE).
High resolution melting (HRM) was originally used to geno-
type Single Nucleotide Polymorphisms (Wittwer et al., 2003)
but was adopted to detect DNA methylation changes in bisulﬁte
treated DNA (Wojdacz and Dobrovic, 2007). Single base differ-
ences can be detected by their distinct melting proﬁles utilizing
speciﬁc ﬂuorescent dyes. The difference between 5-methylcytosine
and cytosine,manifests as a single base change after DNA is treated
with sodium bisulﬁte. With careful primer design to eliminate
PCR bias, it is possible to estimate the methylation levels of a test
sample by comparison of its melting curve with that of a series
of controls of known methylated and unmethylated percentages
(Wojdacz et al., 2008).
The“bisulﬁte revolution”was not limited to the importation of
early genetic techniques to the ﬁeld of DNA methylation;methyla-
tion analysis mentioned earlier in this review would also receive a
renewal. The endonuclease-based protocols used up until the mid
1990s were limited to the detection of a negative result: the absence
of a band indicates a methylated site. This was ﬁrst improved by
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Sadri andHornsby (1996),whereDNAwas ﬁrst treatedwith bisul-
ﬁte according to a revised versionof the 1992bisulﬁte reaction (Feil
et al., 1994), then exposed to two rounds of endonuclease digestion
including a newly created restriction site following bisulﬁte treat-
ment. This innovation was expanded by Xiong and Liard (1997)
to determine the methylation status of individual loci. Combined
bisulﬁte restriction analysis (COBRA), is based on the creation
of new methylation dependant restriction sites, or the retention
of pre-existing ones, by bisulﬁte conversion followed by PCR.
With phosphorimaging, the relative ratio of digested products can
be determined. Although it is a powerful technique, COBRA is
limited to the restriction sites of the enzymes used. Laird et al.
(2004) devised a technique known as “hairpin-bisulﬁte PCR” to
investigate DNA methylation symmetry at a speciﬁc locus. With
bisulﬁte treatment, the required denaturation steps make it dif-
ﬁcult to analyze the methylation pattern of two complementary
DNA strands from one molecule. By ligating a hairpin linker to
restriction-enzyme cleaved DNA, the team were able to establish a
covalent bond between complementary strands of the DNA mol-
ecule, which would allow a PCR product to span the linker and
cover both strands.
REGIONAL METHYLATION LEVELS
Another method already mentioned here that has received a
sodium bisulﬁte facelift is the SssI methyltransferase assay. In
its new incarnation, the enzymatic regional methylation assay
(ERMA), genomic DNA is treated with sodium bisulﬁte prior
to ampliﬁcation of a particular region of interest with non-
discriminating primers containing ﬂanking GATC sites. These
tetranucleotide sequences are required to standardize DNA quan-
tity in this assay, as they are dam sites that accept methyl groups
from dam methyltransferase. To quantify DNAmethylation,E. coli
cytosine methyltransferase SssI was used to speciﬁcally methy-
late the cytosine in all of the CpG dinucleotides that remained
after sodium bisulﬁte treatment, using 3H-labeled S-adenosyl-l-
methionine (SAM) as a methyl donor. For the aforementioned
standardization step, 14C-labeled SAM was incubated along with
dam methyltransferase so the total number of amplicons could be
visualized (Galm et al., 2002).
In 2001, the working draft of the Human Genome was pub-
lished in special issues of Nature and Science (Pennisi, 2001). Later
that year, Human chromosome 20 was fully sequenced, the third
chromosome to be completed in theHumanGenomeProject. This
year was also an important year for DNA methylation and epige-
netics too, because it was here that a new phrase entered the vocab-
ulary of the scientiﬁc community: The Methylome (Feinberg,
2001).
The post-genome era
By the beginning of the twenty-ﬁrst century, a great deal of the
epigenetic landscape had been explored. While the role and mech-
anism of gene regulation via DNA methylation was well under-
stood, the gene-speciﬁc methods described above helped bring
these ideas to the context of complex diseases states, especially
tumorigenesis (Jones and Laird, 1999). However, very little was
known about the genome-wide distribution of 5-methylcytosine
until robust array precipitation methods were devised.
COMPARATIVE METHYLATION PROFILING USING
MICROARRAY TECHNOLOGY
Throughout the 1990s, the development of DNA microarray tech-
nology was responsible for a revolution in functional genomics,
paving the way for high-throughput analysis of single nucleotide
polymorphisms and other genomic variants (Southern et al.,
1999). With the help of these novel tools, the three traditional
lines of attack on the DNA methylation landscape; immunopre-
cipitation,endonuclease digestion,and sodiumbisulﬁte treatment,
would each receive a post-genome era transformation (Figure 2).
These three DNA methylation differentiation and isolation meth-
ods have been the principal approaches used to compare the DNA
methylation patterns between samples over the last decade. In
the microarray assays discussed here, the underlying principle is
the same in each: methylated and unmethylated fragments of the
genome are separated and analyzed. Hybridization to a microar-
ray of known probes allows for quantiﬁcation and identiﬁcation
of areas of the genome that are methylated or unmethylated. All
of the microarray-based techniques discussed here are listed in
Table 4 and are based on one of the three approaches described
below and in Figure 2.
ENDONUCLEASE DIGESTION
Differential methylation hybridization (DMH) was the ﬁrst array-
based method for genome-wide screening of hypermethylated-
CpG islands in tumor cells (Huang et al., 1999). This early
array was only able to asses about 300 CpG islands at a time,
and suffered from major sequence bias. Genomic DNA was ﬁrst
sheared with a methylation insensitive restriction enzyme, MseI.
FIGURE 2 |The three main current approaches for DNA methylation
analysis of genomes.The analyses of DNA methylation patterns across a
genome at varying degrees of resolution involves three main approaches. In
Step 1 methylated and unmethylated cytosines need to be distinguished.
This can be achieved by using methods A, B, or C. (A) Immunoprecipitation
with an antibody against 5mC (Anti-5mC)/methyl-binding protein or
precipitation with speciﬁc methyl-binding proteins. (B) Digestion of DNA
with methyl-sensitive restriction enzymes (RE) that cleave methylated and
unmethylated cytosines differently. (C) Bisulﬁte treatment of DNA will
convert unmethylated cytosines to uracil, which are “read” asTs when PCR
ampliﬁed and sequenced. Methylated cytosines remain as cytosines when
sequenced. The 5mC sites can then be identiﬁed in Step 2 by either using a
microarray or beadchip platform or by next-generation sequencing.
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Table 4 | Applications of microarray technology to differential DNA
methylation analyses.
Method Array type Citation
Methyl-sensitive restriction
enzymes
CGI1 library Huang et al. (1999)
Anti-methylcytosine
immunoprecipitation3
SMRT2 Weber et al. (2005)
Anti-methylcytosine
immunoprecipitation
Promoter array Keshet et al. (2006)
Methyl-binding protein
precipitation4
CGI library Gebhard et al. (2006)
Methyl-binding protein
precipitation
CGI library Rauch et al. (2006)
Sodium bisulﬁte treatment Oligonucleotide Gitan et al. (2002)
Sodium bisulﬁte treatment Oligonucleotide Adorjan et al. (2002)
Sodium bisulﬁte treatment Oligonucleotide5 Reinders et al. (2008)
Sodium bisulﬁte treatment Illumina beadchip Sandoval et al. (2011)
1CGI, CpG island microarray.
2SMRT, submegabase resolution tiling array.
3MeDIP, methylated DNA immunoprecipitation.
4MeCIP, methyl-CpG immunoprecipitation.
5Whole genome oligonucleotide array.
Having a restriction recognition site at TTAA, MseI was unlikely
to interfere with any CpG islands. After the ligation of linkers
to the end of each DNA fragment, half of the pool was treated
with methylation-sensitive BstUI. As a result, the methylated
fragments, and those only treated with MseI remained intact,
and only these could be ampliﬁed via PCR, with primers spe-
ciﬁc to the linkers. These amplicons were differentially labeled
and co-hybridized to a CpG island array. As for any array-based
method, the analysis is limited to the number of genomic ele-
ments represented on the array. The array, used to determine the
methylation status of CpG islands in breast cancer cells, was con-
structed from a physical library of CpG islands generated from
a novel column separation strategy (Cross et al., 1994). Shortly
after it was introduced, DMH was used to detect speciﬁc methy-
lation proﬁles in breast and ovarian cancer cells (Yan et al., 2000;
Ahluwalia et al., 2001). Following on from this, the same group
improved on this method further (Yan et al., 2001; Chen et al.,
2003).
In 2005, the Promoter-associated methylated DNA ampliﬁca-
tion DNA chip was introduced. Contrary to the use of a second
wave of restriction enzymes, the restriction endonuclease McrBC
has been used to fractionate methylated regions of DNA. In a
protocol pioneered by Nouzova et al. (2004), DNA is treated with
MseI, and the fragments are ligated to linkers, in concurrence to the
previous methods. However, the fragments are then divided into
two pools: one to be treated with McrBC, while the other is not.
Unlike the other restriction enzymes discussed so far, McrBC only
cuts at methylated sequences. After PCR, both pools are differen-
tially labeled with Cy3 and Cy5 ﬂuorescent dyes and co-hybridized
to a CpG island array. In the Methylscope platform (Ordway et al.,
2006), DNA fragments are prepared in a similar way, but the DNA
is randomly sheared in the ﬁrst step.
Comprehensive high-throughput arrays for relative methyla-
tion (CHARM) is another platform for array-based methyla-
tion analysis (Irizarry et al., 2008). The workﬂow is based on
some of the methods already mentioned in this section, and
works to eliminate the disadvantages of each. CHARM was con-
ceived while Irizarry and colleagues were comparing three already
established methods for analyzing DNA methylation: methylated
DNA immunoprecipitation (MeDIP), HELP, and fractionation by
McrBC. The HELP assay (HpaII tiny fragment enrichment by
ligation-mediated PCR) is based again on the use of two sets of
restriction enzymes, but the fragments are ampliﬁed via ligation-
mediated PCR and hybridized to a custom microarray along with
separate ﬂuorochromes (Khulan et al., 2006). In the 2008 paper,
Irizarry points out signiﬁcant ﬂaws with each of the array-based
methods in use. MeDIP (also discussed below), was shown to have
a signiﬁcant bias to CpG islands, HELP had incomplete genomic
coverage andMcrBC fractionation displayed location imprecision.
After the rigorous comparison of these methods, the second half
of the paper discusses how a new platform of original array design
strategies and statistical procedures involving genome-weighted
averages from larger genomic areaswas capable of countering these
limitations (Irizarry et al., 2008).
IMMUNOPRECIPITATION
Differentiation between methylated DNA and non-methylated
DNA using anti-methyl antibodies has been discussed already.
However,with the requirement to enrichmethylatedDNAprior to
microarray hybridization, immunological separation techniques
became relevant again.
In 2005, MeDIP was used to immunocapture methylated
cytosines with an antibody speciﬁc for methylated cytosines for
array hybridization (Weber et al., 2005). Prior to immunoprecipi-
tation, genomic DNA was randomly fragmented via sonication or
enzyme restriction. Immunocaptured DNA and control genomic
DNA were both labeled with Cy5 and Cy3 ﬂuorescent dyes, pro-
ducing a ratio of green ﬂuorescence to red ﬂuorescence which
would be indicative of the relative levels of hypermethylation or
hypomethylation. In the 2005 paper, Weber and colleagues used a
submegabase resolution tiling (SMRT) array consisting of 32,433
overlapping BAC clones spanning the entire genome (Ishkanian
et al., 2004;Weber et al., 2005). Independently, Keshet et al. (2006)
devised a similar array-based approach: methyl-DNA immuno-
precipitation (MDIP). They found that tumor speciﬁc methylated
genes are found in clusters on chromosomes, and shared many
structural and functional features. This reinforced the hypothesis
that tumorigenesis arises as a result of de novo mechanisms. One
of the major drawbacks of MDIP and MeDIP is their inability to
pinpointDNAmethylation changes at a single base-pair resolution
(Beck and Rakyan, 2008). However, some argue that since neigh-
boring CpG islands spanning up to 1000 bp are co-methylated in
healthy cells, there is no need for methylation analyses with sin-
gle base-pair resolutions (Eckhardt et al., 2006). In 2006 MDIP
was responsible for producing the ﬁrst complete Methylome: Ara-
bidopsis thaliana (Zhang et al., 2006). Although much smaller
than the mammalian genome, the map of the plant’s methylome
represents an important milestone in epigenetics, while the data
produced was of interest in itself. It was found that one third
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of expressed genes contained DNA methylation in their tran-
scribed regions, and these regions were still highly expressed and
constitutionally active.
Methyl-CpG immunoprecipitation (MeCIP) is another
immunoprecipitation assay similar to MeDIP in terms of the
techniques used and its applications, but a recombinant pro-
tein complex with similar properties to an anti-methylcytosine
antibody is used (Gebhard et al., 2006). Epigenetic gene silenc-
ing via DNA methylation is caused by steric hindrance, resulting
from methylated DNA recruiting methyl-binding domain pro-
teins (MBDs; Thu et al., 2010). In the 2006 paper, Gebhard and
colleagues introduce a recombinant protein made up of MBD2
combined with the Fc tail of a human Ig1 with very high afﬁnity to
single-stranded methylated DNA, stronger than that of the MeDIP
and MDIP methods. Also, it is possible to separate DNA fragments
into fractions of increasing methylation density by eluting with a
salt gradient (Schilling and Rehli, 2007). This approach allows for
the quantiﬁcation of tissue speciﬁc methylation differences for a
wide range of DNA methylation densities.
Another protein complex, MBD3LI bound to MBD2, has also
been shown to have a high afﬁnity to methylated DNA (Rauch
and Pfeifer, 2005). Methylated-CpG island recovery assay (MIRA)
separates fragmented DNA by incubation with a matrix contain-
ing glutathione-S-transferase-MBD2b in the presence of methyl-
CpG-binding domain protein 3-like-1,which increases the afﬁnity
of MBD2b when paired. CpG island methylation can be detected
using PCR or array-based methods (Rauch et al., 2006, 2009).
BISULFITE TREATMENT
In 2002, the principles of DHM were expanded to the use of novel
methylation-speciﬁc oligonucleotide arrays (Adorjan et al., 2002;
Gitan et al., 2002). This time, DNA was prepared for hybridiza-
tion by bisulﬁte modiﬁcation and PCR ampliﬁcation to convert
unmethylated cytosines to thymidine, allowing the epigenetic
modiﬁcation to be detected via traditional hybridizationmethods.
This approach has the potential to detect methylated-CpG islands
at a single-base resolution, but the global conversion of cytosines
to thymidines results in a reduction in sequence complexity, mak-
ing it difﬁcult to design enough unique probes to scale up to a
genome-wide level (Beck and Rakyan, 2008). Although it is possi-
ble to design probes taken from ampliﬁed bisulﬁte treated DNA,
novel approaches have been devised. For small, methylation-rich
genomes, a method called bisulﬁte methylation proﬁling (BiMP)
can be employed (Reinders et al., 2008). The entire genome of
A. thaliana was ampliﬁed using a technique utilizing random
tetranucleotides primers reducing the ampliﬁcation bias usually
associated with bisulﬁte treated DNA. The BiMP data from the
paper was compared to theMDIP results cited earlier (Zhang et al.,
2006). Data from both studies were in concordance, although the
former exhibited proﬁles of considerably higher resolution than
the latter (Reinders et al., 2008). As a result, BiMP is more likely to
pick up speciﬁc, localized changes in DNA methylation patterns
that could prove elusive to detection via MDIP.
The Illumina Beadchip technology, while technically differ-
ent from the types of arrays discussed above, do fall under the
microarray category. Illumina Inﬁnium has been applied to the
DNA methylation analysis. Fryer et al. (2011) examined DNA
methylation patterns at 27,578 CpG sites using the Inﬁnium
HumanMethylation27K in cord blood samples and correlated to
homocysteine levels and birth weight. More recently, Illumina
have launched the Inﬁnium HumanMethylation450Karray which
allows the analysis of >450,000 DNA methylation sites (Sandoval
et al., 2011) with up to 12 samples at a time. This is by far the
most high-throughput comprehensive method available for whole
genome DNA methylation analysis outside of the next-generation
sequencing methods described below.
The use of microarrays for DNA methylation analysis proves
to be a versatile strategy for probing the methylome. Before
hybridization,methylatedDNAcanbepuriﬁedby anumber of dif-
ferent strategies, each with their own unique merits. The strengths
and weaknesses of most of these methods have been systemat-
ically evaluated in Laird (2010). DNA methylation microarrays
provide cheap and accessible genome-wide insights to the DNA
methylation status of a sample, or even a large number of samples.
However, as with the Human Genome Project, there needs to be a
trend toward a gold standard: a perfect assay. Although none exists
at time of writing, only sequencing-based assays have the potential
to provide such a detailed look at the enigmatic methylome, i.e.,
at single-base resolution.
SEQUENCING-BASED APPROACHES
SANGER SEQUENCING
Although the bisulﬁte reaction itself has been adapted and applied
to the conventional genetic techniques aforementioned, the tech-
nology has taken a novel routewhile genome sequencing platforms
have improved as the Human Genome Project progressed over the
subsequent years. At themoment, it is possible to directly sequence
the humangenomewith sophisticated technology; technology that
is starting to be applied to the ﬁeld of DNA methylation. First, it is
worth revisiting how sequencing-basedDNAmethylation analyses
have evolved over the past two decades.
The original bisulﬁte sequencing protocol from Frommer et al.
(1992) suffers from several difﬁculties. For example, relatively large
quantities of genomicDNAare needed for a full proﬁle, limiting its
proﬁciencies in a genome-wide perspective. In 1994, the same lab
(Clark et al., 1994), integrated a PCR ampliﬁcation step to increase
the assay’s sensitivity by 104 fold. The old protocol also required
DNA to be denatured in order to expose the individual bases
to bisulﬁte treatment. Some workarounds have been devised to
counter this, but according to a review by Oakeley (1999), the best
approach at the timewas to denatureDNA in solutionwithNaOH,
then mix with molten agarose. Cooling the agarose locks the DNA
in the denatured conformation, allowing subsequent reactions to
be performed on the agarose block (Olek et al., 1996).
In the pilot study of the Human Epigenome Project, Rakyan
et al. (2004) aimed to proﬁle the DNA methylation patterns of
the human major histocompatibility complex (MHC) located on
chromosome six. This region of the genome was selected as it is
associatedwithmore diseases than any other region of the genome,
and also it’s the most polymorphic area of the genome, so com-
plete sequencing and annotation from the Human Genome was
readily available for the study. This sequencing method was inno-
vative as it did not require a sub-cloning step, but utilized a novel
high-throughput method of direct sequencing of PCR products.
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An algorithm described by Lewin et al. (2004) allows for quantita-
tive analysis of DNA methylation from four-dye electropherogram
data obtained from direct sequencing. Although such data was
previously used in the human genome project and for analyzing
single-base SNPs (Qiu et al., 2003), earlier applications of bisul-
ﬁte treated PCR were impeded by unique technical difﬁculties.
The new software, called epigenetic sequencingmethylation analy-
sis software (ESME), corrects for incomplete bisulﬁte conversion,
performs quality control tests on data, andmapsmethylation posi-
tions to the reference sequence. This approach was also used in a
related paper reporting the DNA methylation proﬁles of human
chromosomes 6, 20, and 22 (Eckhardt et al., 2006).
Reduced representation bisulﬁte sequencing (RRBS) is a ran-
domsequencing-basedmethod for analyzing and comparingDNA
methylation patterns on a genome scale (Meissner et al., 2005).
Size selected BglII fragments of a whole genome were ﬁxed with
ligation linkers and denatured. Bisulﬁte treatment of these frag-
ments yielded single-stranded DNA, as complementarity between
both strands was lost when methylated cytosines were converted
to uracil residues. Converted fragments were ampliﬁed via PCR
and cloned into plasmid vectors for sequencing. Comparison of
the bisulﬁte treated DNA sequence to a reference sequence allows
the operator to pinpoint which cytosines have been methylated,
as those are the only ones to remain cytosines at this stage.
Thymidines that align to cytosines during this comparison stage
represent cytosines that were once unmethylated. RRBS has the
obvious advantage over PCR-based bisulﬁte sequencing methods
in generating a reproducible library of a small, deﬁned area of a
genome. This makes RRBS suitable for comparative methylation
studies across different tissue or cell types.
NEXT-GENERATION SEQUENCING
Up until 2005, most whole genome DNA sequencing strate-
gies were based on the cloning of fragments into bacterial vec-
tors, followed by ampliﬁcation and Sanger sequencing via chain
terminating ﬂuorescent signaling, visualized with capillary elec-
trophoresis (Prober et al., 1987). In recent years, however, a new
parallel sequencing method was developed that did not require a
sub-cloning step. It involves a previously established method for
genotyping known as pyrosequencing, which incidentally has also
been applied to the analysis of gene-speciﬁc/local DNA methy-
lation patterns (Tost and Gut, 2007). The emulsion based PCR
method, described by Margulies et al. (2005), utilizes a pyrose-
quencing protocol optimized for picoliter-scale volumes in the
high density picoliter “reactors” formed by the emulsion droplets.
In 2007, this massively parallel sequencing system (commercial-
ized as Roche 454 FLX) was employed for bisulﬁte sequencing
(Taylor et al., 2007). The pilot study showed robustness and superi-
ority of this approach by analyzing methylation in 25 gene-related
CpG rich regions from over 40 primary cell lines. During the
process, speciﬁc four-nucleotide tags were added to the 5′end
of each primer, so each amplicon could be individually indexed,
pooled, and manipulated (Taylor et al., 2007).
Further advances in next-generation sequencing including the
Illumina/Solexa Genome Analyzer and the Applied Biosystems
SOLiD™ System (reviewed in Mardis, 2008) has meant that going
forward, most genome-wide DNA methylation protocols will
Table 5 | Approaches for DNA methylation analyses by
next-generation sequencing.
Method Genome coverage Citation
Bisulﬁte
sequencing
Whole genome Cokus et al. (2008)
MeDIP-seq1
anti-5mC
Enriched Methylated DNA Maunakea et al. (2010)
MBDiGS2 Enriched Methylated DNA Serre et al. (2009)
MRE-seq3 Size selected fraction Maunakea et al. (2010)
MMSDK4 Representative genome tags Li et al. (2009)
1Sequencing of immunoprecipitated anti-5mC DNA.
2Methyl-binding protein precipitated sequencing.
3Methyl-sensitive restriction enzyme sequencing.
4Modiﬁed methylation-speciﬁc digital karyotyping.
feature some form of next-generation sequencing. The current
gold standard is to carry out whole genome bisulﬁte sequenc-
ing of target samples where a reference genome is available.
However, the costs for such an approach are still not triv-
ial and adaptations of methods to produce a representation of
genome-wide DNA methylation have been developed. Table 5
describes some of the current options for DNA methylation
analysis in combination with next-generation sequencing and are
described below. It is worth noting that similarly to microar-
ray analysis, for next-generation sequencing, the three principle
approaches still employ sodium bisulﬁte treatment, immuno-
precipitation, and the utilization of methyl-sensitive restriction
enzymes (Figure 2).
WHOLE GENOME SEQUENCING-BISULFITE TREATMENT
An entire DNA methylome can be assessed at a single nucleotide
resolution with sodium bisulﬁte treatment followed by whole
genome sequencing. This approach has been taken to generate a
DNA methylation map of A. thaliana (Cokus et al., 2008). Unlike
previous genome-wide approaches, this allowed for the sensitive
measurement of cytosine-methylation across the genome with
sequence speciﬁc contexts. When compared to array-based meth-
ods, the authors reported the discovery of new methylation sites
in previously inaccessible areas of the genome. A whole genome
approach was also recently applied to mammalian cells. The ﬁrst
humanDNAMethylome in embryonic and fetal cells at single-base
resolution was recently published (Lister et al., 2009), identify-
ing a signiﬁcant proportion of non-CG methylation. Additional
single-base resolution human methylomes continue to be pub-
lished (Maunakea et al., 2010) highlighting the importance of
intragenic DNA methylation in the regulation of gene expression.
Thus, the elusive Human DNA Methylome is more complex than
previously thought.
The whole genome approach is the most desirable with unlim-
ited resources, but realistically for a lot of laboratories this is not an
approach that can be taken for the analysis of numerous samples.
A more cost effective approach is to reduce the complexity of the
genome in order to reduce the amount of sequencing required per
sample. The methods described below are some examples of how
this can be done.
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METHYLATED DNA IMMUNOPRECIPITATION SEQUENCING
The methylated DNA immunoprecipitation sequencing (MeDIP-
seq) approach incorporates the anti-methylcytosine antibody
described earlier. Brieﬂy, methylated DNA is immunoprecipi-
tated using the antibody against 5-methylcytosine and sequenced
(Maunakea et al., 2010; Table 5). The portion of DNA that is
immunoprecipitated represents the methylated portion of DNA
and is identiﬁed by comparison to the reference genome.
METHYL-BINDING DOMAIN ISOLATED GENOME SEQUENCING
Methyl-binding domain isolated genome sequencing (MBDiGs)
uses recombinant MBD and MBD2 proteins to enrich methyl-rich
DNA fragments from a pool of sonicated genomic DNA (Serre
et al., 2009). According to the review by Hirst and Mara (2010),
MBDiGS is preferable over MeDIP-seq because a gradient in salt
concentrations can be used to elute DNA fragments at different
rates depending on their methylation status.
METHYL-SENSITIVE RESTRICTION ENZYME SEQUENCING
Methyl-sensitive restriction enzyme sequencing (MRE-seq), as its
name suggests, involves methylation-sensitive restriction enzymes
(Maunakea et al., 2010). Genomic DNA samples are digested with
the restriction enzymes and the subsequent DNA fragments are
size selected and sequenced. Differential DNA methylation may
be identiﬁed by comparison of the fragments sequenced between
samples and site speciﬁc information is identiﬁed by comparison
to a reference genome. This method analyses a different portion
of the genome compared to MeDIP-seq and therefore, they can be
viewed as complimentary approaches.
MODIFIED METHYLATION-SPECIFIC DIGITAL KARYOTYPING
Modiﬁed methylation-speciﬁc digital karyotyping (MMSDK) or
MSDK-seq (Li et al., 2009) is similar to MRE-seq in that a methyl-
sensitive restriction enzyme is employed but includes additional
steps that reduce the amount of sequencing required. Rather than
sequencing sections of the genome, speciﬁc regions of the genome
can be identiﬁed from their short sequence tags. This signiﬁcantly
reduces the amount of sequencing and in turn reduces the costs
of this approach.
COMPARISON OF CONTEMPORARY DNA METHYLATION
METHODS
In this review, we aim to detail the development and evolution of
these analytical methods over time with respect to advancements
made in genetics, nucleotide biochemistry, and DNA sequencing
technology. As a result, many of the methods discussed are obso-
lete today and have been replaced by more recent technologies.
However, some of the techniques described in the latter part of this
review have subtle strengths andweaknesses, and careful judgment
should be employed in adopting any of thesemethods in a research
laboratory. There are many recent reviews that compare most
recent methods of DNA methylation analysis as mentioned below.
Laird (2010) list the features and source of bias for vari-
ous sequencing and microarray-based techniques including CpG
ambiguity, fragment size bias, cross-hybridization bias. All of the
methods that involve sodium bisulﬁte treatment, they argue, are
subject to incomplete bisulﬁte conversion bias. Thu et al. (2010),
also compare the strengths and weaknesses of each method, with
a special focus on techniques based on immunoprecipitation. In
more detail, a paper byHarris et al. (2010) quantitatively compares
the sequencing-based methods MethylC-seq, RRBS, MeDIP-seq
and MBD-seq (2010). Due to the nature of their processes, the
two bisulﬁte-based methods yield data with single base-pair reso-
lution, augmentedwith the capacity to quantifymethylation levels.
At a reduced coverage, the enrichment methods both have a lower
cost-per-CpG in a genome-wide context, but not allowing precise
quantiﬁcation of methylation levels on a genome-wide scale. It
appears that none of the currently available methods are without
their ﬂaws but bisulﬁte treated whole genome sequencing offers
complete genome coverage at single-base resolution and is cur-
rently the method of choice for genome-wide DNA methylation
analysis where costs are not prohibitive.
FUTURE OF METHYLOME ANALYSIS
The Next-generation sequencing approaches for DNA methyla-
tion analysis will dominate for themoment.However, themethods
discussed here cannot detect non-cytosine related methylation
reactions, i.e., N6-methyladenine nor 5-hydroxymethylcytosine
and therefore, more sophisticated methods are required than cur-
rently on offer. Newer sequencing technologies such as single-
molecule real-time (SMRT) sequencing (Flusberg et al., 2010)
can directly detect all known DNA methylation reactions with-
out the need for bisulﬁte treatment and is likely to take over from
next-generation sequencing in the very near future.
The analysis of 5-hydroxymethylcytosine (5hmC) via HPLC
based methods has been discussed brieﬂy. Recently, two novel
approaches have been described to discern the genomic distrib-
ution of 5hmC (Pastor et al., 2011). The ﬁrst, called GLIB involves
the glucosylation, periodate oxidation, and biotinylation of 5mhC.
Biotin molecules can be added to newly formed aldehyde groups
on pretreated 5hmC. A glucose moiety is added to 5hmC via a
glucosyltransferase enzyme, which has its vicinal hydroxyl groups
converted to aldehydes via treatment with sodium periodate. We
have previously discussed at lengthhow sodiumbisulﬁte treatment
of 5mC does not result in a conversion in a similar time-frame
to unmethylated cytosine. However, treatment of 5hmC yields
another molecule: 5-methylenesulfonate. For the second method
discussed in the article, Pastor et al. (2011) have succeeded in selec-
tively isolating biotinylated 5hmC and sodium bisulﬁte converted
5hmC using streptavidin and anti-5-methylenesulfonate, respec-
tively. In another recent publication,Kinney et al. (2011) exploited
an isoschizomer pair of restriction enzymes, MspI and HpaII, that
can differentiate between 5hmC and its glucosylated form. Cou-
pled with qPCR, the team found that ES and brain cell genomic
DNA contains a considerable amount of 5hmC, and identiﬁed
novel loci containing 5hmC in both mouse ES and human brain
DNA (Kinney et al., 2011).
CONCLUSION
The major developments in the methodologies for proﬁling and
ﬁngerprinting the human methylome have followed a clear pro-
gression toward innovative sequencing techniques at a single
base-pair resolution. As this technology improves, the cost of
genome-wide sequencing will decrease, resulting in a new wave
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of DNA methylation data as more labs become fully immersed
in the ﬁeld. The bioinformatic tools will continue to improve in
order to accurately analyze the vast datasets that will no doubt be
generated in the coming years. The precedent for this has already
been set through the Human Genome Project. Earlier this year,
the International Human Epigenome Consortium was launched,
aiming to map 1000 Epigenome by 2020 (IHEC, 2010). This is by
no means an easy task, but if we see as many technical advances in
the ﬁeld in the next 10 years as we have in the previous decade, it
is a challenge we are more than capable of facing.
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